job cuts
Merck to close Irish plant with loss of 570 jobs
December 2, 2013Manufacturing and Production, Sales and Marketing Ireland, MSD, Merck, job cuts, swords
Merck & Co has said it plans to close down a facility in Ireland with the loss of around 570 …
Merck KGaA swings axe over Serono operations
April 25, 2012Manufacturing and Production, Research and Development, Sales and Marketing Cladribine, MS, Merck KGaA, Switzerland, job cuts
Merck KGaA will cut around 500 jobs from its pharmaceutical unit in Switzerland, the firm has announced. The company said …
Genzyme to close UK site
February 24, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, UK, job cuts
Genzyme will close its Cambridge R&D site by the end of the year, with a loss of around 60 jobs. …
Alnylam cuts workforce by a third
January 23, 2012Research and Development, Sales and Marketing Alnylam, Novartis, job cuts, rnai
Alnylam will cut 33% of its workforce this year as it looks to focus on developing its own products. The …
Takeda to cut 2,800 jobs
January 19, 2012Business Services, Research and Development, Sales and Marketing Nycomed, Takeda, job cuts
Takeda has announced plans to significantly reduce its global headcount over the next four years following its merger with Nycomed. …
Novartis reverses plant closure decision
January 18, 2012Manufacturing and Production, Research and Development, Sales and Marketing Basel, Diovan, Novartis, Nyon, closure, job cuts
Novartis has said it will not close down a plant in Switzerland that had been due for closure, and has …
Novartis to cut 2,000 US jobs
January 13, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diovan, Novartis, job cuts
Novartis will slash 1,960 jobs in the US as it prepares for life without its blockbuster medicine Diovan. The hypertension …
Novartis workers stage flash strike over job cuts
November 21, 2011Manufacturing and Production Novartis, Switzerland, job cuts
Workers at Novartis’ Nyon facility in Switzerland carried out a strike to protest the closure of the plant, but called …
Novartis job cuts protest
October 31, 2011Manufacturing and Production, Sales and Marketing Novartis, job cuts, manufacturing and production
Protesters have been demonstrating outside the home of Novartis chairman Daniel Vasella and in the streets of Basel, Switzerland, in …
Pfizer to cut 11% of its workforce in Spain
September 22, 2011Sales and Marketing Pfizer, Spain, job cuts
Pfizer will cut 220 jobs in Spain as the government reduces spending on pharmaceuticals to help offset its growing debt …
Slow Provenge growth prompts Dendreon staff cull
September 13, 2011Business Services, Manufacturing and Production Dendreon, Provenge, job cuts, pharma manufacturing news
After months of building manufacturing capacity, US biotech Dendreon has decided to slash a quarter of its workforce – with …
Job cuts at AstraZeneca’s US manufacturing plant
May 24, 2011Manufacturing and Production AstraZeneca, job cuts
AstraZeneca says it will cut around 135 positions at its manufacturing facility in Westborough, Massachusetts, from the end of this …
Lilly cuts jobs in Ireland
May 23, 2011Manufacturing and Production Ireland, job cuts, lilly, manufacturing and production
Eli Lilly has said it is downsizing its plant in County Cork, Ireland, by around 14% in light of patent …
Novartis to close UK research site
March 16, 2011Research and Development Horsham, Novartis, job cuts, pharma job cuts
[UPDATE: Novartis has confirmed it will close its manufacturing site in Horsham, but continue to conduct respiratory research at the site …
Pfizer’s CRO plans for Sandwich will have limited impact
March 15, 2011Business Services, Research and Development Jobs, Kent, Pfizer, Sandwich, job cuts
Pfizer’s efforts to attract contract research organisations to take over part of its Sandwich research site will only benefit a …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
